Richard William Scalzo, SVP, Head of Finance & Administration at Dyne Therapeutics, Inc. (DYN), sold 24,916 shares at $27.50 ($698K) on 2024-02-29, disclosed to the SEC on 2024-03-01.
Scheduled sale ($698k) by SVP, Head of Finance & Administration under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 3,429 | $94K | 13.5% |
| 2 | $27.50 | 3,429 | $94K | 13.5% |
| 3 | $28.22 | 8,747 | $247K | 35.3% |
| 4 | $28.22 | 8,747 | $247K | 35.3% |
| 5 | $28.65 | 564 | $16K | 2.3% |
| Total | $28.03 avg | 24,916 |
| $698K |
| 100% |
| Filing → |
| DYN | SELL | 2025-03-13 | $15K | — | Filing → |
| DYN | SELL | 2025-03-07 | $11K | — | Filing → |
| DYN | SELL | 2025-02-18 | $35K | — | Filing → |